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ABSTRACT 
 
Electrospinning of a segmented copolymer having polyglycolide hard segments was 
successfully performed from 1,1,1,3,3,3-hexafluoroisopropanol solutions. During the 
process, a bactericidal agent, i.e. chlorhexidine (CHX), was effectively loaded, which 
resulted in nanofibers with a smaller diameter because of the change in solution 
conductivity. New fabrics based on molding of alternate layers of poly(ε-caprolactone) 
(PCL) films and the electrospun scaffolds of the segmented copolymer were prepared 
and characterized. The thermal molding process rendered a PCL matrix homogeneously 
reinforced with nanofibers that compensated for the loss of mechanical properties 
caused by incorporation of CHX. 
Release of CHX was evaluated in different media. Results varied depending on the layer 
where the drug was incorporated. Thus, systems with an immediate bacteriostatic effect, 
as well as systems with a potential long term antimicrobial effect, were obtained. 
Growth inhibition and adhesion assays demonstrated the fast bactericidal effect of 
samples with CHX loaded in its outer layers.   
 
 
 
 
 
 
Keywords: Biocompatibility, biodegradable, block copolymers, poly(ε-caprolactone), 
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INTRODUCTION 
Electrospun nanofibers have great potential as reinforcing materials due to their 
anisotropy and high surface/volume ratio. They can also be used for encapsulation of 
drugs due to their high drug loading capability as provided by the electrospinning 
process. The mechanical properties of polymer matrices are generally affected by the 
addition of drugs. This can be counteracted by using suitable reinforcing agents. 
Furthermore, drug release can be tuned by appropriate choice of nanofiber  composition 
and of drug loading area (e.g. slow and fast releases should be expected when drugs are 
incorporated in the matrix or the filler, respectively). Several recent works focus on the 
use of electrospun micro/nanofibers as fillers and demonstrate the improvement of 
mechanical properties of derived composites [1-5]. In this sense, good distribution of 
fibers and absence of interleaves are significant factors that must be taken into account 
[5].  
Drug release behavior can be modified by varying the composition of the encapsulating 
system. For example, tuned release of a model drug such as triclosan can be achieved by 
employing electrospun fibers prepared from different mixtures of polylactide and 
poly(ε-caprolactone) [6]. A similar effect can be attained from copolymers with 
different compositions, among which poly(lactic acid-co-glycolic acid) (PLGA) is 
probably the most widely studied. It is also worth considering the use of segmented 
copolymers because they could provide better properties than the above random 
copolymers. Furthermore, it seems possible to have control over the final mechanical 
performance by changing the ratio between the stiff hard blocks and flexible soft blocks 
which characterize the segmented architecture [7].  
Poly(ε-caprolactone) (PCL) is a biodegradable, biocompatible, easily processed 
polymer. Despite significant disadvantages such as poor barrier properties, low melting 
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temperature and low modulus, PCL has wide applications in tissue engineering, drug 
delivery and packaging [8-10]. Therefore, PCL appears as an ideal matrix for successful 
loading of biodegradable, biocompatible nanofillers which improve its mechanical 
properties and extend its range of application as a drug delivery system. 
Although electrospun fibers of polyglycolide (PGL) seem good fillers due to their 
relatively high degradation rate and high tensile modulus, it should be considered that 
PGL has a highly hydrophilic character, which contrasts with the hydrophobicity of 
PCL. A lack of surface adhesion between PCL and PGL homopolymers resulting in 
limited benefits in terms of mechanical properties is expected. The use of electrospun 
fibers from PCL and PGL mixtures has been considered a good alternative to improve 
adhesion and make load transfer from the PCL matrix to the stronger fiber 
reinforcement feasible [11]. Specifically, it was determined that incorporation of 40 wt-
% of fibers constituted by equivalent percentages of PCL and PGL led to increased 
yield strength. 
The present work aims to evaluate the use of segmented polymers incorporating 
compatible ε-caprolactone units as reinforcing materials. Poly(GL)-b-poly(GL-co-
TMC-co-CL)-b-poly(GL) (Figure 1a) was selected because it is a commercial 
bioabsorbable suture (Monosyn®) with high crystallinity, good mechanical properties 
and high biodegradability [12-15]. Monosyn® is constituted by two polyglycolide hard 
segments and a relatively hydrophobic soft segment that corresponds to a weight of 
43%. The middle soft segment is characterized by a random distribution of ɛ-
caprolactone residues (32.5 wt-%), together with glycolide (35 wt-%) and trimethylene 
carbonate (32.5 wt-%) units [16]. 
Electrospinning of PGL copolymers having a segmented architecture has not been 
undertaken up to now. Even electrospinning of polyglycolide has scarcely been 
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addressed despite its wide application in the biomedical field. Nevertheless, it has been 
reported that PGL electrospun nanofibers can be prepared from 8 wt-% in HFIP 
solution, with an average fiber diameter of 310 nm and a diameter distribution between 
50 and 650 nm [17].  
A multilayer system is a new approach to obtain reinforced matrices. The use of 
different layers combining polymeric films and electrospun scaffolds allows mechanical 
properties and even drug release to be tailored by appropriate selection of the layer 
where the pharmacological agent is incorporated.  
The present work focuses on a system formed by five layers, three of poly(ε-
caprolactone) films and two of electrospun poly(GL)-b-poly(GL-co-TMC-co-LA)-b-
poly(GL) mats (Figure 1b). The use of this kind of systems for controlling drug release 
is evaluated using a hydrophilic drug such as CHX (1,1′-hexamethylene-bis-5-(4-
chlorophenyl)biguanide) (Figure 1a). This drug is very interesting due to its high 
antimicrobial activity [18]. Specifically, protonated secondary amines of CHX can be 
attached to negatively loaded (anionic) phospholipids of the bacterial membranes [19], 
causing the desestabilization of the cell wall and interfering with osmosis. It is expected 
that CHX can be quickly delivered from a hydrophobic matrix into a hydrophilic 
medium. For this reason, it is a good model to evaluate loading capability from different 
configurations to achieve delayed release. 
EXPERIMENTAL SECTION 
Materials 
Commercially available violet sutures of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-
poly(GL) (Monosyn®, USP 0) with a weight average molecular weight of 90,700 g/mol 
were kindly supplied by B. Braun Surgical, S.A. Poly(ε-caprolactone) (PCL) (Mw: 
5 
 
65000 g/mol), chlorhexidine diacetate (CHX) and phosphate buffered saline (PBS - 
Dulbecco’s Phosphate Buffer Saline) were purchased from Sigma-Aldrich. 
Ethanol absolute and methanol were purchased from Scharlab and 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP) from Apollo Scientific.  
Reagents and labware for microbial culture were also obtained from Scharlab. The 
bacterial strains Escherichia coli CECT 101 and Staphylococcus aureus CECT 245 
were obtained from the Spanish Type Culture Collection (Valencia, Spain). 
Measurements 
Tensile properties of 1 cm x 2 cm samples of PCL films, electrospun mats and the 
resulting matrices were studied at room temperature and humidity using a universal 
tensile testing instrument Zwick Z2.5/TN1S with a 100 N load cell equipped with a 
testXpert 8.1 program. Thickness of specimens depended on the preparation method. 
Specifically, values of 0.2, 0.05 and 0.7 mm were determined for films, electrospun 
mats and melt pressed matrices, respectively. Initial distance between clamps was 10 
mm and crosshead speed was 10 mm/min. The reported Young’s modulus and tensile 
strength were averaged values of at least five specimens. 
Scanning electron microscopy (SEM) was employed to examine the morphology of 
electrospun fibers and fracture surfaces. Carbon coating was accomplished with a Mitec 
k950 Sputter Coater (fitted with a film thickness monitor k150x (Quorum Technologies 
Ltd., West Sussex, UK). SEM micrographs were taken with a Zeiss Neon 40 EsB 
instrument (Carl Zeiss, Oberkochen, Germany). 
Calorimetric data were obtained by differential scanning calorimetry with a TA 
Instruments Q100 series with Tzero technology and equipped with a refrigerated cooling 
system (RCS). Experiments were conducted under a flow of dry nitrogen at a heating 
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rate of 20 ºC/min with a sample weight of approximately 5 mg. Calibration was 
performed with indium.  
Thermal degradation was determined at a heating rate of 10 ºC/min with around 5 mg of 
samples in a Q50 thermogravimetric analyzer of TA Instruments under a flow of dry 
nitrogen and in the temperature range from 50 to 600 ºC.  
Electrospinning of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
Electrospinning of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) was carried out in 
HFIP with a polymer concentration of 10 w/v-%. CHX loaded samples were obtained 
by adding 0.5 w/w-% of the drug in the electrospinning solution. 
Electrospun fibers were collected on a rotating grounded collector operating at 30 rpm 
and at a variable distance (10-15 cm) at room temperature. The voltage was varied 
between 10 and 30 kV and applied to the collector using a high-voltage supplier 
(Gamma High Voltage Research, ES30-5W). The polymer solution was delivered via a 
KDS100 infusion syringe pump (KD Scientific, USA) to control the flow rate (from 3.5 
to 10 mL h-1).  
Unloaded and CHX loaded electrospun fibers were prepared using optimized 
parameters (i.e. needle-collector distance, voltage and flow rates) and solvent conditions 
(i.e. specific solvent and polymer concentration). 
Preparation of loaded and unloaded PCL films 
PCL films were prepared by pressing 0.7 g of PCL in a 4 cm x 6 cm flat mold heated at 
15 ºC above the melting point of PCL (i.e. 60 ºC) for 8 min at a pressure progressively 
increasing from 1 to 2 bars. A hydraulic press, heated platens and a temperature 
controller were employed. The mold and polymer were covered with Teflon® sheets in 
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order to avoid polymer adhesion to the heated plates. PCL films with a thickness close 
to 200 μm were recovered after cooling the mold to room temperature.  
CHX was incorporated by solvent casting. Specifically, 0.7 g of PCL and 3.5 mg of 
CHX (i.e. 0.5 w/w-%) were dissolved in 10 mL of an ethanol/chloroform 1:2 (v/v) 
mixture and the resulting solution was allowed to evaporate at room temperature. The 
obtained films were cut in small pieces and melt pressed as above explained. Smooth 
films with a similar thickness (i.e. 220 μm) were obtained. 
Preparation of multilayered matrices 
Layers of PCL films and poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) electrospun 
mats were assembled alternately to obtain a five layer system, as shown in Figure 1b. 
Specifically, the two outer and the middle sheets corresponded to PCL films (i.e. film-
mat-film-mat-film). These five layers placed in a mold of 1 cm x 2 cm x 0.5 cm internal 
dimensions were heated at 75 ºC (i.e. 15 ºC above the PCL melting point) for 15 min 
using heating plates and a temperature controller. A pressure of 1 ton was applied to the 
assembly after the heating process by hydraulic press. The mold and polymeric 
assembly were covered with Teflon® sheets in order to avoid polymer adhesion to the 
heated platens. After melt pressing the reinforced matrices were obtained. The molten 
PCL layers allowed to put together the different layers, leading to macroscopically 
homogeneous samples in which poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
electrospun fiberss were embedded into the PCL matrix. The resulting matrices had a 
thickness close to 700 μm and a PCL content close to 80 wt-%.  
Different combinations of CHX loaded and unloaded layers, i.e. loading of CHX in one 
of the outer layers (PCLe), in the inner PCL layer (PCLi), in one electrospun mat (M(i)) 
and in the two electrospun mats (M(ii)), were evaluated. CHX load percentages were 
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close to 0.5 wt-%, 0.5 wt-%, 0.07 wt-% and 0.14 wt-% for PCLe, PCLi, M(i) and M(ii) 
systems, respectively. 
Drug release 
Drug release experiments were performed with 1 cm × 1 cm square pieces (thickness 
close to 700 µm) representative of each drug loading configuration. These pieces were 
incubated at 37 ºC in an orbital shaker at 80 rpm in tubes of 10 mL for 1 week. A 3:7 v/v 
mixture of PBS buffer and ethanol was used as the release medium. Additional 
experiments were also carried out in an ethanol medium and even in PBS when CHX 
was incorporated in the outer layer of PCL (PCLe). Samples were withdrawn from the 
release medium at predetermined time intervals and drug concentration was evaluated 
by UV spectroscopy using a Shimadzu 3600 spectrometer. Absorbance was measured at 
a wavelength of 260 nm. Calibration curves were prepared using different stock 
solutions of the assayed CHX drug in the different release media and relating the 
measured absorbance to concentration. The volume of the release medium was kept 
constant during the experiments by addition of fresh medium. All drug release tests 
were carried out using three replicates and the results were averaged.  
Encapsulation efficiency was calculated by measuring the amount of drug incorporated 
into the scaffold by UV-vis absorbance measurements at a wavelength of 260 nm. 
Samples were dissolved in 0.5 mL of HFIP and subsequently the polymer was 
precipitated by addition of ethanol (0.5 mL). CHX was separated by centrifugation and  
dissolved in the solvent phase.  
Antimicrobial test assays 
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E. coli and S. aureus bacteria were selected to evaluate the antimicrobial activity of 
CHX loaded matrices. The bacteria were previously grown aerobically to exponential 
phase in broth culture (5 g/L yeast extract, 5 g/L NaCl, 10 g/L tryptone, pH 7.2). 
Growth experiments were performed on a 24-well culture plate. All CHX loaded 
samples (1 cm x 1 cm and thickness close to 700 µm) were placed into each well and an 
unloaded sample was used as a blank. Then, 2 mL of broth culture containing 103 CFU 
was added to the samples. Cultures were incubated at 37 °C and agitated at 80 rpm. 
Aliquots of 100 μL were taken at predetermined time intervals for absorbance 
measurement at 650 nm in a microplate reader (every 2 h for 8 h, and after 12, 24 and 
48 h from the starting time). Thus, turbidity was directly related to the relative bacterial 
growth by considering the maximum growth attained in the absence of any polymeric 
matrix (control). 
Bacterial adhesion on matrices was also determined. Upon completion of growth 
experiments, culture media were aspirated and the material was washed three times with 
distilled water. Then, 0.5 mL of sterile 0.01 M sodium thiosulfate was added to each 
well to detach adhered bacteria. After 1 h agitation (100 rpm) at 37 ºC, samples were 
removed and 1 mL of broth culture was added in each well. After filling the plate with 
fresh broth culture, the first sample was taken as a time 0 for adhesion assay. Then, 
plates were incubated at 37 ºC and 100 rpm for 24 h. Bacterial number was determined 
as above indicated. All assays were conducted in quadruplicate and values were 
averaged. 
In order to perform a qualitative evaluation, the pieces (1 cm ×1 cm × 700 µm) of CHX 
loaded samples and an unloaded one, which was used as a blank, were placed into an 
agar diffusion plate and seeded separately with 104 CFU/mL of each bacterium. The 
culture medium was prepared with 18.5 g Brain Heart Infusion broth, 7.5 g BactoTM 
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Agar in 1 L of Milli-Q water and sterilized in an autoclave at 121 ºC for 30 min. Plates 
were filled with 15 mL of medium and left to rest at room temperature to allow 
solidification of the medium. Inhibition halo images were taken after incubation of 
samples with bacteria at 37 ºC for 24 h.  
RESULTS AND DISCUSSION 
Electrospinning of unloaded and CHX loaded poly(GL)-b-poly(GL-co-TMC-co-
CL)-b-poly(GL) nanofibers 
Low solubility of polymers having significant polyglycolide blocks limited the selection 
of an appropriate solvent for the electrospinning process to HFIP. A polymer 
concentration around 10 wt-% was found adequate to obtain nanofibers as previously 
described for polyglycolide (i.e. 8 wt-% in HFIP solution) [17]. Needle-collector 
distance had a limited influence on fiber morphology, and specifically distances 
between 12 and 15 cm allowed continuous and well-formed nanofibers to be obtained 
under most  assay conditions. Lower values did not ensure complete solvent evaporation 
while, for longer distances, the population of narrower fibers increased.  
The greatest difficulty in obtaining appropriate fiber morphology lay in the formation of 
a large proportion of irregular beads and even in the disruption of the electrospun 
nanofibers. Table 1 summarizes some representative experiments showing a beneficial 
effect at increased  applied voltage and decreased flow rate. It is well known that the 
stretching process is enhanced at high voltages [20] whereas the decrease in the flow 
rate leads to small fiber diameters [21]. Solvents cannot be uniformly and completely 
evaporated at high flow rates, leading to the formation of abundant beads and even 
merging of fibers into a web [22]. The selected conditions (Table 1) corresponded to a 
voltage of 25 kV, a flow rate of 3.5 mL/h and a needle-collector distance of 12 cm 
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(Figures 2 and 3). Small variations led to defective morphologies, as shown in Figures 
2a, 2b and 2c for higher flow rates and lower applied voltages.  
SEM micrographs at different magnifications (Figures 3a, 3b and 3c) show that highly 
uniform and continuous nanofibers with smooth surfaces can be obtained under the 
selected processing conditions. Figure 4a plots a wide diameter distribution curve (i.e. 
from 200 to 900 nm) which follows a unimodal distribution. Most fibers have a 
diameter around 410 nm, with the average diameter being 500 nm and the standard 
deviation 118 nm.  
The characteristics of the solution were drastically modified when the ionic CHX 
compound was added since, logically, the electrical conductivity of the solution 
changed. It is well established that an increase of solution conductivity tends to reduce 
fiber diameter because of the increase in electrical charge carried by the jet, and 
therefore in resulting tensile force, in the presence of an electric field [23]. Processing 
conditions were also modified (Table 1) in order to avoid fiber disruption and formation 
of droplets at low flow rates. In any case, continuous and homogeneous nanofibers 
(Figures 3d, 3e and 3f) could be obtained at 5 mL/h keeping both applied voltage (i.e. 
25 kV) and needle-collector distance (i.e. 12 cm). High magnification SEM images 
(Figure 3e) revealed a smooth fiber surface, but also the presence of some very small 
crystals that could be attributed to CHX. They also showed the presence of two fiber 
populations, as could also be deduced from the diameter distribution in Figure 4b. The 
more abundant population corresponds to an average diameter of 150 nm and a standard 
deviation of 38 nm, whereas values of 320 nm and 90 nm characterize the other one. At 
any rate, the maximum diameter was close to 600 nm, a value significantly lower than 
that determined for unloaded fibers (i.e. 900 nm).   
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Preparation of multilayered PCL matrices containing poly(GL)-b-poly(GL-co-
TMC-co-CL)-b-poly(GL) nanofibers 
The thermal molding process allowed nanofibers to be successfully integrated in the 
PCL matrix. In fact, only some edges of the molded pieces reveal the five-layered 
configuration, as shown in Figure 5a, probably because of deficient pressure on the 
borders of the mold. Nevertheless, comparison of Figures 5b and 5c demonstrates the 
ability of PCL to flow into electrospun scaffolds because of its moderate viscosity at the 
molding temperature and the porosity of scaffolds. Figure 5b illustrates the initial 
morphology, where a scaffold appears surrounded by two PCL films whereas Figure 5c 
shows how the different layers cannot be distinguished in the inner sections of the piece 
after completion of the molding process. The presence of fibers relatively well 
distributed in the matrix can be envisaged in high magnification images (see arrows in 
the inset of Figure 5c). It is worth noting that the fracture surfaces of molded pieces 
obtained after cracking them in liquid nitrogen had a homogeneous appearance similar 
to that observed for the initial PCL films (see inset in Figure 5c). 
NMR spectra (Figure 6a) allowed the final composition of multilayer matrices and, 
specifically, the weight percentages of PCL and the segmented copolymer to be 
determined. The last gave rise to a complex spectrum due to the sequence sensitivity of 
the different units (i.e. glycolic acid, ε-caprolactone and trimethylene carbonate), which 
had well-differentiated signals associated with the different types of glycolic acid 
protons in the 4.9-4.5 ppm range and minor signals associated with trimethylene 
carbonate and ε-caprolactone units. The spectrum of multilayer samples showed 
predominant peaks associated with PCL and, specifically, a clear triplet at 2.24 ppm that 
corresponds to the CH2CO protons. The weight percentage of the segmented copolymer 
(Cop-%) was determined with equation 1 taking into account the areas of representative 
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peaks (i.e. A4.9-4.5 and A2.3-2.2 for glycolyl and ε-caproyl units, respectively), the 
molecular weights of glycolyl (i.e. 58 g/mol) and ε-caproyl units (114 g/mol), and 
finally the weight percentages of glycolyl (72%) and ε-caproyl (14%) residues in the 
segmented copolymer. 
Cop-% = (A4.9-4.5 × 58) / [(A4.9-4.5 × 58) + (A2.3-2.2 - (A4.9-4.5 × 58 × 0.14 /0.72))] × 100      (1) 
Composition was analyzed by sampling the diagonal of the molded pieces at four 
equidistant points. Results revealed a highly homogeneous composition (i.e. Cop-% 
varied between 18 and 22 %) that was in full agreement with the theoretical value (20 
%) deduced from the weight of PCL films (ca. 48 mg) and scaffolds (ca. 12 mg) 
introduced in the mold. That is, losses caused by the flow of molten PCL were 
negligible.  
The FTIR spectrum of the multilayer matrix (Figure 6b) showed predominant PCL 
bands, although those corresponding to PGL could also be distinguished. Bands at 1414, 
972 and 902 cm-1 are significant because they are assigned to the crystalline phase of 
PGL [24], with the two first peaks being clearly detected in the multilayer matrix. 
Spectra of loaded matrices were similar due to the complexity of the FTIR spectra and 
the small amount of incorporated drug. 
Thermal properties of multilayered PCL matrices containing poly(GL)-b-poly(GL-
co-TMC-co-CL)-b-poly(GL) nanofibers 
DSC heating scans of electrospun scaffolds (Figure 7) revealed that the segmented 
copolymer was able to crystallize during the electrospinning process. The first heating 
scan was characterized by a very complex melting peak indicative of the existence of 
crystalline lamellae with different thicknesses. The first peak appeared around 170 ºC 
whereas the last and most intense one was observed around 193 ºC. The intensity ratio 
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between peaks varied depending on the region of the scaffold and, specially, between 
samples processed in different batches. Note, for example, the different relative 
intensity of the peak at 170 ºC in the inset of Figure 7a. The high melting temperatures 
are associated with the fusion of polyglycolide hard segments (i.e. 229 ºC is the reported 
equilibrium melting temperature of polyglycolide [24]) and its enthalpy allowed the 
crystallinity of the sample to be estimated considering a value of 11.8 kJ/mol for a 
100% crystalline polyglycolide [25]. Crystallinities of 22% and 21% were thus 
determined for the as processed scaffold and the melt crystallized sample (Figure 7b), 
respectively. These crystallinities increased to 39% and 37% when were referred to the 
hard segment content (i.e. the melting enthalpy was recalculated taking into account the 
weight percentage of polyglycolide hard segments in the copolymer). The DSC heating 
scan of melt crystallized samples basically corresponded to the melting of thick lamellae 
since only a peak at 192 ºC was detected. On the other hand, once again a very broad 
melting peak indicative of the presence of lamellae with different thicknesses was 
observed for samples quenched from the melt state. Nevertheless, no well-defined low 
temperature peak could be distinguished in this case. Melting enthalpies of melt 
crystallized (i.e. cooled from the melt at a rate of 10 ºC/min) and quenched samples (i.e. 
cooled from the melt at the maximum rate allowed by the equipment) were highly 
similar, as can be deduced from the heating traces in Figures 7c and 7d. Associated 
enthalpies were high and indicative of the great ability of the segmented copolymer to 
crystallize. Calculated crystallinities (i.e. 21% and 20%) were slightly lower than those 
determined for the electrospun samples, showing that crystallization was easier when 
polymer chains were oriented by the electrospinning process despite the reduced time 
involved in the evaporation of the solvent. The heating scan of the melt quenched 
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sample showed a single glass transition temperature at 3 ºC, which indicates a miscible 
amorphous phase constituted by soft and non-crystallized hard segments. 
For the sake of completeness, the DSC trace of the final CHX loaded multilayer matrix 
is shown in Figure 7e. In this case, melting peaks associated with the fusion of PCL 
(melting peak at 57 ºC) and PGL can be distinguished, and thus crystallinities of 64% 
(16.2 kJ/mol was considered as the melting enthalpy for 100% crystalline PCL [26]) 
and 82% were obtained for the PCL and PGL crystalline phases, respectively. These 
percentages were determined considering the content of PCL and PGL hard blocks in 
the scaffold. Note that the crystallinity of the PGL phase was clearly enhanced by a 
thermal annealing process during molding. Logically, PGL had a complex fusion, with 
peaks at 171 ºC and 193 ºC. In this case, the predominant peak was 171 ºC, suggesting 
that thinner lamellae were stabilized during the annealing process, thus hindering 
recrystallization/reordering into thicker lamellae during heating. Finally, the heating run 
of a melt-crystallized sample (Figure 7f) showed that only the population of the thickest 
PGL lamellae was produced during crystallization as only the peak at 193 ºC was 
observed. The incorporated CHX drug did not have a remarkable influence on thermal 
behavior because DSC traces could not be distinguished from those obtained of 
unloaded samples (not shown).  
TG and DTG curves (Figure 8) showed the high thermal stability of the multilayer 
matrices, which had an onset degradation temperature of 250 ºC and decomposed 
according to two steps with DTG peak temperatures at 350 ºC and 410 ºC. These 
degradation processes were in full agreement with those observed for the nanofibrous 
scaffold (i.e. single peak at 350 ºC) and the PCL film (i.e. single peak at 410 ºC), with 
the weight loss associated with the first step being smaller due to the lower content of 
nanofibers (i.e. 19 wt-%) in the matrix.  
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It is clear that the multilayer sample could be prepared without any evidence of thermal 
degradation because nanofibers were obtained by electrospinning at room temperature 
and the molding process was performed at a temperature different from that at the 
beginning of decomposition due to the low melting temperature of PCL. However, TG 
and DTG curves of CHX showed a relatively low stability that could affect the 
processing of multilayer matrices. Specifically, CHX had a complex three step 
degradation process with an onset degradation temperature of 175 ºC and DTG peak 
temperatures of 250 ºC, 355 ºC and 466 ºC. Incorporation of CHX in the electrospun 
scaffold had a remarkable influence on its onset degradation temperature, which 
decreased to 200 ºC despite the low amount of loaded drug (ca. 0.5 wt-%). Furthermore, 
the temperature of the first DTG peak decreased from 355 ºC to 330 ºC. In addition, a 
char yield close to 4% was detected in the corresponding DTG curve, in agreement with 
the high residue observed in the degradation of the CHX drug caused by its high 
aromatic content. Although in this case processing was not problematic due to the low 
temperature range, the thermogravimetric result is interesting because it points out that 
caution should be taken when other polymers with a higher melting point (e.g. 
polylactide) are selected as matrices. 
Mechanical properties of multilayered PCL matrices containing poly(GL)-b-
poly(GL-co-TMC-co-CL)-b-poly(GL) nanofibers 
Representative stress-strain curves of the different fabrics are shown in Figure 9. 
Several points deserve attention: 
a) Unloaded scaffolds have low Young’s modulus (i.e. 20 MPa), as expected for an 
electrospun sample. This modulus is limited due to slippage between nonwoven fibers. 
Final deformation and maximum stress become close to 170% and 2 MPa, respectively. 
The latter value clearly increased (i.e. 5 MPa) when the scaffold was loaded with CHX 
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while modulus and final strain remained similar. The differences observed in fiber 
morphology (e.g. a significant reduction in diameter) were due to the incorporation of 
CHX. 
b) PCL films showed a typical behavior characterized by high elastic modulus (i.e. 180 
MPa) due to high crystallinity of PCL, maximum stress of 9 MPa at the necking point 
and a plastic region that extends to a final deformation higher than 200% (i.e. 600% not 
shown). These properties changed drastically when CHX was incorporated even for a 
low percentage such as 0.5 wt-%.  Thus, maximum stress decreased to 7 MPa and 
deformation to 20%. Crystallization was also slightly hindered, and consequently 
modulus decreased to 165 MPa. 
c) The unloaded multilayer matrix had slightly higher Young’s modulus than the PCL 
film (i.e. from 180 MPa to 220 MPa) due to the incorporation of nanofibers. In addition, 
an increase in maximum stress (i.e. 17 MPa) indicative of a reinforcing effect, and 
therefore of the existence of relatively good interactions between the matrix and the 
nanofibers, was observed. Elongation at break (i.e. 55%) was lower than that of the 
matrix due to the stiff nature of the added fibers. It should be emphasized that 
multilayer matrices having CHX loaded in the nanofibers showed clearly improved 
properties (235 MPa, 23 MPa and 55% for Young’s modulus, maximum stress and final 
deformation, respectively) since the nanofiber diameters decreased, as above indicated. 
The most important conclusion is that these loaded multilayer samples displayed 
significantly better properties than PCL films having similar drug loading. 
CHX release from multilayer matrices 
Release behavior was first studied in ethanol medium because it has a great ability to 
swell the polymer matrix and favor drug delivery. Furthermore, ethanol is also a good 
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solvent of CHX. That is why results about the use of ethanol appear useful to highlight 
the ability of the different layers to retain the drug, if that is the case.  
Figure 10a shows almost immediate release for the drug loaded in the outer PCL layer, 
with complete delivery being achieved after only 30 h of exposure. Release was also 
fast for the drug loaded the inner PCL layer, although in this case more than 100 h was 
required to obtain a relative release percentage of 98%. Basically, the difference in the 
release of  CHX loaded in the outer and the inner PCL films is due to the variation of 
the diffusion path of the drug.  
In contrast, a significantly different behavior was observed when the drug was 
incorporated into the scaffolds. Logically, increased retention could not just be due to an 
increased diffusion path. Therefore, it should be considered that CHX can establish 
better interactions with the hydrophilic PGL rich copolymer than with the hydrophobic 
PCL. Interestingly, Figure 10 also shows that different release profiles were attained 
depending on whether the drug was incorporated in one or both scaffolds. Thus, in the 
first case, release was 90% after 100 h of exposure while in the second case it was only 
80% after the same period. The increased amount of loaded nanofibers clearly hindered 
drug release since it had more chance to interact with them. Note that an opposite result 
should be expected because of the higher drug concentration inside the matrix when 
both scaffolds were loaded. 
Delivery of CHX into aqueous PBS medium was insignificant, even when the drug was 
loaded in the outer PCL layer (i.e. 15% after 100 h) (Figure 10b, solid line). It is clear 
that water was unable to swell the hydrophobic polymer properly, and thus facilitate 
drug diffusion. Differences with the other loaded matrices were, logically, irrelevant. 
Figure 10b also illustrates that the release behavior in function of the ethanol/water 
ratio. Specifically, the system with CHX in both scaffold layers shows the highest 
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sensitivity for a decrease of the ethanol content from 100% to 70%. Note, for example, 
that the release percentage for the M(ii) configuration decreased from 80% to 70% after 
100 h of exposure. This difference in behavior can also be evaluated quantitatively 
through the decrease in the release constant from 0.10 h-0.5 to 0.08 h-0.5 when a typical 
Higuchi equation is applied:[27,28]  
Mt ⁄ M0 = kH t(1⁄2) ,     (2) 
where kH is the Higuchi release constant, Mt is the percentage of drug released at time t, 
and M0 is the maximum percentage of released drug. 
Antibacterial properties of CHX loaded matrices 
The antimicrobial effect of CHX loaded matrices was evaluated quantitatively by 
considering the growth curves of Gram-negative (E. coli) and Gram-positive (S. aureus) 
bacteria, (Figures 11a and 11b). Clearly, the unloaded matrix is highly susceptible to 
bacterial infection, with a latency phase that extends over a period of 4 h and followed 
by an exponential growth (log) phase. A significant decrease in bacterial proliferation 
was only detected when CHX was loaded in the outer PCL film. Nevertheless, the 
growth curve was again characterized by similar latency and exponential growth phases.  
Results indicate that an immediate bacteriostatic effect was attained by incorporating 
the drug in the outer layers. However, the possibility of having a drug reservoir for long 
term events is also interesting. In this sense, it is clear that loading of CHX in the inner 
electrospun scaffolds led to greater drug release after 2000 min (i.e. after the drug from 
PCL was completely delivered). Interestingly, growth inhibition during the period of 8 
to 24 h was slightly higher for the M(ii) multilayer matrix than for the unloaded blank 
and even for the PCLe sample (note the decrease in the slope of the S. aureus growth 
curves). In fact, bacterial adhesion tests (Figure 12) reveal that PCLe was the only 
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loaded matrix with a clear bacteriostatic effect for long term assay (24 h) and that S. 
aureus was more sensitive to CHX than E. coli. Thus, adhesion was 90 % and 85 % 
with respect to the control for E. coli and S. aureus, respectively. The bactericidal effect 
was also evaluated qualitatively by agar tests, i.e. measuring the inhibition halos around 
the multilayer fabrics. This method is highly problematic to evaluate the bactericidal 
effect of hydrophilic drugs such as CHX since their release in the hydrophobic agar 
medium is difficult. Results (Figure 13) point out that inhibition halos were only 
significant for PCLe samples, regardless of the type of bacteria, and show a clear 
bactericidal activity due to the unfavorable test medium that had been expressly chosen. 
Logically, samples loaded in the nanofibers did not show bactericidal activity in these 
short time events.  
 
CONCLUSIONS 
Segmented copolymers having 57 wt-% of polyglycolide hard segments and soft 
segments constituted by glycolide, trimethylene carbonate and ε-caprolactone units can 
be successfully electrospun from HFIP diluted solutions. Continuous and uniform 
nanofibers with an average diameter of 500 nm and a smooth texture were attained 
using voltage, flow rate and needle-collector distance of 25 kV, 3.5 mL/h and 12 cm, 
respectively. Increase of flow rate and decrease of voltage had a strong effect on fiber 
morphology. Specifically, bead formation was clearly enhanced. 
Electrospinning allowed fibers loaded with a bactericidal drug, i.e. chlorhexidine, to be 
obtained, although processing parameters had to be modified because of the increase in 
electrical conductivity of the solution. A bimodal diameter distribution was achieved, 
with 150 and 320 nm being the mean diameters of the two populations. 
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Electrospun nanofibers were highly crystalline, as revealed by FTIR and DSC 
measurements. Incorporation of CHX had little influence on crystallinity because the 
expected negative effect could be compensated by the higher polymer orientation 
attained in the stretched nanofibers. 
Molding of a five layer assembly of alternate PCL films and electrospun scaffolds based 
on a PGL rich copolymer gave rise to a PCL matrix reinforced with well distributed 
nanofibers. Favorable interactions were probably established between the matrix and the 
soft segments containing ε-caprolactone. Enhancement of mechanical properties of 
loaded multilayer matrices proved that the presence of nanofibers could compensate for 
the decrease in mechanical performance of PCL layers loaded with CHX. 
Drug release experiments revealed that the multilayer system was able to ensure fast 
release of CHX loaded in the outer PCL layers while delayed delivery was achieved for 
CHX loaded in the nanofibers due to the good interactions established between the drug 
and the hydrophilic polyglycolide component. This tunable release behavior appears 
highly interesting to obtain a short and long term bactericidal effect, as demonstrated by 
growth inhibition and cell adhesion experiments. 
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FIGURE CAPTIONS 
Figure 1. a) Chemical structures of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
(MonosynTM), poly(ε−caprolactone) and the selected CHX hydrophilic drug. b)  
Schematic representation showing the distribution of layers and the different CHX 
loading configurations. 
Figure 2. Optical micrographs showing the improvement of fiber morphology by 
decreasing flow rate and increasing applied voltage. A considerable number of beads 
were observed at 5 mL/h and 12.5 kV (a), which contrasts with the number of uniform 
fibers obtained at 3.5 mL/h and 25 kV (d). For the sake of completeness, fibers obtained 
under intermediate conditions are also shown; 5 mL/h and 15 kV (b) and 3.5 mL/h and 
15 kV (c). 
Figure 3. SEM micrographs showing unloaded (a,b,c) and CHX loaded (d,e,f) 
poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) electrospun nanofibers at different 
magnifications. Nanofibers were obtained under optimized conditions. 
Figure 4. Diameter distribution curves of unloaded (a) and CHX loaded (b) poly(GL)-
b-poly(GL-co-TMC-co-CL)-b-poly(GL) electrospun nanofibers obtained under 
optimized conditions. 
Figure 5. SEM micrographs showing the lateral edge of the final multilayer matrix (a), 
the assembly of an electrospun mat between two PCL films before the melt pressing 
process (b) and a lateral view of the inner part of the matrix after being cracked in liquid 
nitrogen (c). The insets show a magnification where nanofibers can be distinguished as 
it is pointed by the red arrows and a section of the initial PCL film. 
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Figure 6. a) NMR spectrum of a multilayer matrix with assignment of main peaks. b) 
FTIR spectrum showing characteristic bands of PCL and poly(GL)-b-poly(GL-co-
TMC-co-CL)-b-poly(GL) polymers. Blue arrows point out  the characteristic PGL 
bands associated with the crystalline phase that can be detected in the electrospun 
scaffold. 
Figure 7. DSC heating (a), cooling (b) and subsequent heating (c) scans of poly(GL)-b-
poly(GL-co-TMC-co-CL)-b-poly(GL) electrospun nanofibers. The inset of a) shows the 
melting peak observed for another scaffold processed under the same conditions. d) 
Heating scan of a melt quenched electrospun sample. e) Heating scan of a CHX loaded 
multilayer piece. f) Heating scan of a CHX loaded multilayer piece after crystallizing 
from the melt state.  
Figure 8. TGA (a) and DTGA (b) curves for the indicated representative samples. 
Figure 9. Stress-strain curves of poly(GL)-b-poly(GL-co-TMC-co-CL)-b-poly(GL) 
elcetrospun mats (green lines), PCL films (red lines) and multilayer matrices (orange 
lines).  Unloaded and CHX loaded samples are represented by dashed and solid lines, 
respectively. 
Figure 10. CHX release percentages in EtOH (a) and PBS-EtOH 30:70 (b) media for 
the different loading configurations of the multilayer matrix. For the sake of 
completeness, data in PBS medium are also plotted (solid line) for the configuration 
where CHX is loaded in the outer PCL films (PCLe). 
Figure 11. Growth curves of E. coli (a) and S. aureus (b) in the CHX loaded multilayer 
matrices and the unloaded one used as a blank. 
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Figure 12. Adhesion of E. coli (gray bars) and S. aureus (grid bars) on the CHX loaded 
multilayer matrices. Data concerning the culture plate as positive control and the 
unloaded matrix as blank are also provided. 
Figure 13. Images showing inhibition halos on agar plates seeded with E. coli and S. 
aureus caused by multilayer matrices with loaded outer PCL film and the electrospun 
mat. Images of blanks (unloaded matrices) are also provided. 
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Table 1. Morphology of unloaded and CHX loaded electrospun poly(GL)-b-poly(GL-co-
TMC-co-CL)-b-poly(GL) samples induced depending on processing parameters (voltage, 
flow rate and needle-collector distance) . 
 
  
Assay Voltage 
(kV) 
Flow 
(mL·h-1) 
Distance 
(cm) Results 
Electrospun fibers 
1 12.5 5 12.5 Many beads 
2 15 5 15 Some beads 
3 15 8 15 Some beads 
4 15 3.5 12 Few beads 
5 20 3.5 12 Few beads 
6 25 3.5 12 No beads 
Electrospun fibers with CHX 
1 25 3.5 12 Many beads 
2 20 3.5 12 More beads. Disruption on fiber  
3 20 7 12 Less beads but many fibers with oval droplet-like shape 
4 20 5 12 Many beads 
5 25 5 12 No beads and only few oval droplet-like shape fibers 
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